Teladoc Health Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Chuck Divita
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | less than a year |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 7.1yrs |
| Gemiddelde ambtstermijn bestuur | 6.1yrs |
Recente managementupdates
Recent updates
Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 02
Is Teladoc Health (NYSE:TDOC) A Risky Investment?
Oct 23Teladoc: Double-Digit FCF Yield, Possible BetterHelp Transition
Oct 13Teladoc Health, Inc. (NYSE:TDOC) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Sep 18Teladoc Health: Some Negative Things, But One Aspect That Makes Me Feel Positive
Sep 15Teladoc: Prospects Are Ready For Better Health
Sep 04Teladoc Post Q2 Earnings: Stick A Fork In This Stock - It's Nearly Done (For)
Aug 01Teladoc's Vital Signs: Why 5x FCF Means Stable Health (Rating Upgrade)
Jul 22Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors
Jul 17Teladoc Health: Weight Loss Management Could Help
Jul 01Would Teladoc Health (NYSE:TDOC) Be Better Off With Less Debt?
Jun 04Teladoc: Stock Likely To Be Range Bound Until Guidance Is Revised Upwards
May 31Teladoc: Huge Execution Problem
Apr 27Teladoc: Improving Business Trends (Rating Upgrade)
Apr 17Teladoc: Management Has A Lot To Prove To Gain Investor Confidence
Mar 25Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues
Mar 10Teladoc Health: Another Bad Quarter, Another Wave Of Capitulation
Feb 21Teladoc Health: Weight Management Rescue
Jan 21Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt
Jan 15When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?
Dec 12Teladoc Q3: Getting Stronger (Rating Upgrade)
Nov 29Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price
Nov 22Teladoc Was Obliterated
Oct 25Is Teladoc Health (NYSE:TDOC) A Risky Investment?
Oct 11Teladoc: Broken Growth Story Deteriorates Further (Rating Downgrade)
Oct 02Teladoc Stock: A Hold Amid New Covid Wave
Sep 14Teladoc's Technical Decline Hints At A Buying Opportunity
Aug 28Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?
Aug 18Buy Teladoc: AI Will Likely Spur Healthcare Deflation
Aug 16Teladoc's Future: Virtual Healthcare, AI, And Valuation
Jul 28Teladoc And Microsoft's Expanded Strategic Partnership Is A Powerful AI Combo
Jul 21The Big Trends: New Frontiers in Healthcare
Jul 13
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?
Jul 10Teladoc Health: Likely To Remain Out Of Favor
Jun 26Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors
Jun 25Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt
May 25Teladoc: BetterHelp Segment Margins Are Key
May 23Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?
May 06Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?
Mar 10Teladoc Health Non-GAAP EPS of -$0.23 misses by $0.04, revenue of $637.7M beats by $4.33M
Feb 22CEO
Chuck Divita (54 yo)
less than a year
Tenure
Mr. Charles Divita, III is CEO and Director at Teladoc Health, Inc. since June 2024. He served as Florida Combined Life Insurance Company, Inc. from 2018 to 2024. He had been Executive Vice President of Co...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chief Financial Officer | 5.4yrs | US$5.94m | 0.050% $ 815.7k | |
| Chief Operating Officer | 2.3yrs | US$4.80m | 0.045% $ 744.6k | |
| Chief Legal Officer & Secretary | 9.8yrs | US$3.54m | 0.027% $ 439.8k | |
| CEO & Director | less than a year | geen gegevens | geen gegevens | |
| Co-Founder | 22.8yrs | geen gegevens | geen gegevens | |
| Senior VP & Chief Accounting Officer | less than a year | geen gegevens | geen gegevens | |
| Chief Technology Officer | no data | geen gegevens | 0.044% $ 717.1k | |
| Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Executive Vice President of Corporate Development | 9.8yrs | US$2.07m | 0.012% $ 197.6k | |
| Chief Marketing Officer & Engagement Officer | 8.8yrs | US$2.01m | 0.028% $ 464.5k | |
| Chief People Officer | 4.1yrs | geen gegevens | 0.026% $ 427.2k | |
| Chief Strategy Officer | 9.8yrs | geen gegevens | 0.018% $ 299.3k |
7.1yrs
Gemiddelde duur
53yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van TDOC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.1 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | less than a year | geen gegevens | geen gegevens | |
| Independent Director | 15yrs | US$290.00k | 0.023% $ 371.7k | |
| Independent Director | 8.2yrs | US$294.49k | 0.0086% $ 140.8k | |
| Independent Non-Executive Chairman | 10.8yrs | US$332.50k | 0.069% $ 1.1m | |
| Independent Director | 4yrs | US$280.00k | 0.023% $ 384.4k | |
| Independent Director | 7.8yrs | US$285.00k | 0% $ 0 | |
| Independent Director | 6.1yrs | US$283.00k | 0.0049% $ 79.4k | |
| Independent Director | 4.8yrs | US$280.00k | 0.012% $ 194.0k | |
| Independent Director | 1.2yrs | US$264.69k | 0.0024% $ 38.6k |
6.1yrs
Gemiddelde duur
69yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van TDOC wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.1 jaar).